Puraclenz’s ozone-free technology is over 99% effective at reducing the MS2 virus in the air. MS2 bacteriophage is an FDA-recognized proxy virus of SARS-CoV-2, the virus that causes COVID-19.
Efficacy tests confirm that a Puraclenz P3000 unit is proven to be over 99.7% effective at reducing dangerous bacteria Methicillin-Resistant Staphylococcus epidermis in the air.
Independently conducted efficacy tests confirm that a Puraclenz P3000 unit is proven over 95% effective in reducing Aspergillus brasiliensis (a black mold endospore) in the air.
Puraclenz ions proactively clean difficult-to-reach surfaces, reduce the risk of human error, and enable continuous coverage in the most challenging environments.